Progyny/PGNY

$39.87

3.1%
-
1D1W1MYTD1YMAX

About Progyny

Progyny, Inc. is a fertility benefits management company. The Company specializes in fertility and family-building benefits solutions in the United States. The Company provides its benefit through its Smart Cycle approach. The Smart Cycles include medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provides care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.

Ticker

PGNY

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

David Schlanger

Employees

393

Headquarters

New york, United States

Progyny Metrics

BasicAdvanced
$3.71B
Market cap
74.79
P/E ratio
$0.52
EPS
1.49
Beta
-
Dividend rate

What the Analysts think about Progyny

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 9 analysts.
17.06% upside
High $49.00
Low $45.00
$39.87
Current price
$46.67
Average price target

Progyny Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
5.62% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$280.8M
0.54%
Net income
$15.8M
6.04%
Profit margin
5.62%
5.44%

Progyny Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 36.59%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.03
$0.18
$0.15
$0.16
-
Expected
$0.01
$0.07
$0.10
$0.12
$0.10
Surprise
157.14%
142.31%
43.84%
36.59%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Progyny stock

Buy or sell Progyny stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing